SPP1 and hydrops fetalis: Osteopontin (OPN), a matricellular phosphorylated glycoprotein [7,8] and a proposed therapeutic HF target [9], is known to balance inflammatory processes, induce expression of genes responsible for cardiomyocyte hypertrophy [10,11,12], and participate in intercellular communication [13].